Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001493152-22-021919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-08+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $24.31 | -15.6K | 2,954 | -84% | -$380.3K |
| DM | 2022-08-10 | 2022-08-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +15.6K | 6,943 | New | +$27.2K |
| DM | 2022-08-10 | 2022-08-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $0.00 | -15.6K | 32.6K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | S | D | 2,791 | $24.52 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.345 to $24.70, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-08-09 | S | D | 5,909 | $23.84 | 2,791 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.34 to $24.34, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-08-09 | M | A | 8,700 | $1.74 | 8,700 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-08 | S | D | 2,954 | $24.94 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.81 to $25.43, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-08-08 | M | A | 6,943 | $1.74 | 6,943 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-08 | S | D | 3,989 | $24.39 | 2,954 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.80 to $24.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-08-08 | M | D | 6,943 | $0.00 | 41,350 | D | $1.74 · — to 2030-09-03 | 6,943 Common Stock | (F6) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-08-09 | M | D | 8,700 | $0.00 | 32,650 | D | $1.74 · — to 2030-09-03 | 8,700 Common Stock | (F6) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |